0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover1754.51%IV-1090.48%PremiumDec 20, 2024Expiry Date6.87Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8797Delta0.2389Gamma0.09Leverage Ratio-0.0271Theta-0.0003Rho-0.08Eff Leverage0.0001Vega
Equillium Stock Discussion
is this stock still even alive
$Equillium (EQ.US)$
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, recently announced promising topline results from its Phase 2 proof-of-concept (PoC) study of EQ101 in adult patients suffering from moderate, severe, or very-severe alopecia areata (AA). This autoimmune condition, driven by an immune cell attack on hair follicles, leads...
No comment yet